论文部分内容阅读
目的观察康莱特注射液提高晚期癌症患者生存质量的作用。方法本组收集两家医院肿瘤科126例晚期癌症患者临床治疗资料,每位患者给予康莱特注射液100ml VDqd×20天,观察治疗后疼痛缓解,KPS变化,体重变化及不良反应。结果癌症疼痛缓解总有效率达76.99%(部分缓解60.32%,完全缓解16.67%),用药结束后疼痛缓解仍可维持2～6天;经康莱特治疗后91.27%(115126)的患者KPS评分提高,其中提高20以上达69.84%;未发现康莱特注射液对心、肝、肾功能方面的毒副作用。结论康莱特有明显提高晚期癌症患者的生存质量,且无明显毒副作用。
Objective To observe the effect of Kanglaite injection on improving the quality of life of patients with advanced cancer. Methods The clinical data of 126 patients with advanced cancer were collected from two hospital oncology departments. Each patient was given Kanglaite Injection 100ml VDqd for 20 days. The pain relief, KPS changes, weight changes and adverse reactions were observed after treatment. Results The total effective rate of cancer pain relief was 76.99% (60.32% partial remission and 16.67% complete remission). Pain relief could still be maintained for 2 to 6 days after the end of treatment; KPS scores improved in 91.27% (115126) patients after KLT treatment. , which increased by 20 or more to 69.84%; no toxic side effects of Kanglaite injection on heart, liver, and kidney function were found. Conclusions Kanglaite can significantly improve the quality of life of patients with advanced cancer without obvious side effects.